More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/AADAC Polyclonal Antibody
Western Blot analysis of Human fetal liver and liver cancer tissue using AADAC Polyclonal Antibody at dilution of 1:600
Western Blot analysis of Human fetal liver and liver cancer tissue using AADAC Polyclonal Antibody at dilution of 1:600
Western Blot analysis of Human fetal liver and liver cancer tissue using AADAC Polyclonal Antibody at dilution of 1:600

AADAC Polyclonal Antibody

Research Use Only
E-AB-10690
Elabscience
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Elabscience
  • Product Name
    AADAC Polyclonal Antibody
  • Delivery Days Customer
    12
  • Applications Supplier
    ELISA WB IHC
  • Certification
    Research Use Only
  • Concentration
    0.2mg/ml
  • Scientific Description
    Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens. Displays major serine hydrolase activity in liver microsomes. Hydrolyzes also flutamide, which is an antiandrogen drug used for the treatment of prostate cancer that occasionally causes severe hepatotoxicity. Displays cellular triglyceride lipase activity in liver. Increases intracellular fatty acids derived from hydrolysis of newly formed triglyceride stores.
  • UNSPSC
    12352203